Background illustration for clinical trials search

Paid Clinical Trials Cleveland

Discover 1,399 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

for
Interstitial Lung Disease
Location: Cleveland OH, Chicago IL, Richmond VA, New York NY,
Sponsor: aTyr Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05892614

Phase2, Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Cleveland OH, Farmington MI, Dayton OH, Cincinnati OH,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase3, Recruiting

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for
Solid Tumor
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Fairfax VA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06874335

Phase1, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: Cleveland OH, Detroit MI, Toronto, Grand Rapids MI,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase3, Recruiting

Transition to KPL-387 Monotherapy Dosing & Administration Study

for
Recurrent Pericarditis, Heart Diseases, Pericarditis
Location: Cleveland OH, Cincinnati OH, Charlottesville VA,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07288216

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

for
Malignant Neoplasm of Bladder,
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 19+

Code: NCT06290687

Phase2, Recruiting

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

for
Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Location: Cleveland OH, Cincinnati OH, Indianapolis IN,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07010159

Phase2, Phase3, Recruiting

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

for
Liver Diseases, Alcoholic
Location: Cleveland OH, London, Toronto, Indianapolis IN,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70

Code: NCT06613698

Phase2, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

for
Hypoxic-Ischemic Encephalopathy
Location: Cleveland OH, Morgantown WV, Indianapolis IN, Durham NC,
Sponsor: ReAlta Life Sciences, Inc.

Sex: All

Age: 0

Code: NCT05778188

Phase2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Cleveland OH, Detroit MI, Toledo OH, Rochester Hills MI,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

for
Parkinson Disease
Location: Cleveland OH, Farmington Hills MI, Chicago IL,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 40 - 70+

Code: NCT06976268

Phase2, Phase3, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Cleveland OH, Detroit MI, Pittsburgh PA, Ann Arbor MI,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Baltimore MD,
Sponsor: Tvardi Therapeutics, Incorporated

Sex: All

Age: 18+

Code: NCT05440708

Phase1, Phase2, Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: Celveland OH, Royal Oak MI, Sewickley PA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase3, Recruiting

Immediate Versus Delayed Loading of Maxillary Overdenture Implants

for
Implant Complication
Location: Cleveland OH, Morgantown WV
Sponsor: Case Western Reserve University

Sex: All

Age: 21+

Code: NCT06038487

Recruiting

Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums

for
Recession, Gingival
Location: Cleveland OH
Sponsor: Case Western Reserve University

Sex: All

Age: 18+

Code: NCT06037161

Recruiting

Longitudinal Study of Urea Cycle Disorders

for
Brain Diseases, Metabolic, Inborn,
Location: Cleveland OH, Toronto, Washington DC, Philadelphia PA,
Sponsor: Andrea Gropman

Sex: All

Age: 0+

Code: NCT00237315

Recruiting

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

for
Clear Cell Renal Cell Carcinoma, Solid Tumors
Location: Cleveland OH, Detroit MI, Pittsburgh PA, Baltimore MD,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05536141

Phase1, Recruiting

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Cleveland OH, Pittsburgh PA, Buffalo NY, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05061550

Phase2, Recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Cleveland OH, Columbus OH, Brampton, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06467357

Phase3, Recruiting